TRILLIUM THERAPEUTICS INC. Increase (Decrease) in Accounts Payable
TRILLIUM THERAPEUTICS INC. reported Increase (Decrease) in Accounts Payable of -$6.50 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accounts payable for the quarter ending 2021-09-30 was -$287.00K, a 111.49% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accounts payable for the quarter ending 2021-06-30 was $363.00K.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accounts payable for the quarter ending 2021-03-31 was -$6.58M.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accounts payable for the quarter ending 2020-12-31 was $4.33M.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accounts payable for fiscal 2020 was $6.30M, a 349.29% increase from fiscal 2019.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accounts payable for fiscal 2019 was $1.40M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $76.00K derived: sum of 2 quarters · filed 2021-11-12 | -$6.50M 10-Q · filed 2021-11-12 | -$2.17M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$6.21M 10-Q · filed 2021-08-13 | -$1.88M derived: sum of 3 quarters · filed 2021-08-13 | $618.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | -$6.58M 10-Q · filed 2021-05-07 | -$2.24M derived: sum of 2 quarters · filed 2021-05-07 | $255.00K derived: sum of 3 quarters · filed 2021-11-12 | -$57.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $6.83M derived: sum of 2 quarters · filed 2021-11-12 | $6.52M derived: sum of 3 quarters · filed 2021-11-12 | $6.30M 10-K · filed 2021-03-18 |
| 2020-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.19M derived: sum of 2 quarters · filed 2021-11-12 | $1.96M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$533.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$221.00K 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $1.40M 10-K · filed 2021-03-18 |